Drugs Made In America Acquisition Corp. Rights (DMAAR) Technical Analysis

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$0.20

$0.01 (2.63%)

Last update: 02:50 PM EST

Day's range

$0.19

$0.2

Technical Analysis

The latest Technical Analysis Summary on Stocks.News offers insights into market trends using key Technical Indicators like RSI and MACD, alongside Moving Averages such as the 50-day and 200-day. The analysis identifies buy and sell signals through bullish or bearish crossovers, helping investors make informed trading decisions.

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.

Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.

In future if you don't want to receive any email then delete stocks added into alert section.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.

Stocks News

Drugs Made In America Acquisition Corp. Rights (DMAAR) Technical Analysis

$0.20

$0.00

Technical Analysis

Stocks News

Drugs Made In America Acquisition Corp. Rights (DMAAR) Technical Analysis

$0.20

$0.00

Technical Analysis

Explore Related Stocks for Market Trends

Select an alert type

Setup alert

Exclusive Content